NDC 65649-701

OsmoPrep

Sodium Phosphate, Monobasic, Monohydrate, Sodium Phosphate, Dibasic Anhydrous

OsmoPrep is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals, Inc.. The primary component is Sodium Phosphate, Monobasic, Monohydrate; Sodium Phosphate, Dibasic, Anhydrous.

• Product ID: 65649-701_47561fab-810d-4e6b-9774-09a83be38369
• NDC: 65649-701
• Product Type: Human Prescription Drug
• Proprietary Name: OsmoPrep
• Generic Name: Sodium Phosphate, Monobasic, Monohydrate, Sodium Phosphate, Dibasic Anhydrous
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2006-05-15
• Marketing Category: NDA / NDA
• Application Number: NDA021892
• Labeler Name: Salix Pharmaceuticals, Inc.
• Substance Name: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
• Active Ingredient Strength: 1 g/1; g/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 65649-701-41

100 TABLET in 1 BOTTLE, PLASTIC (65649-701-41)

• Marketing Start Date: 2006-05-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 65649-701-41 [65649070141]

OsmoPrep TABLET

• Marketing Category: NDA
• Application Number: NDA021892
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2006-05-15

NDC 65649-701-32 [65649070132]

OsmoPrep TABLET

• Marketing Category: NDA
• Application Number: NDA021892
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2006-05-15
• Marketing End Date: 2017-02-28

Drug Details

Active Ingredients

Ingredient	Strength
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	1.102 g/1

OpenFDA Data

• SPL SET ID: b46c0b17-c49b-4791-913f-3e6e1fdbe88e
• Manufacturer:
  • Salix Pharmaceuticals, Inc.
• UNII:
  • 593YOG76RN
  • 22ADO53M6F
• RxNorm Concept Unique ID - RxCUI:
  • 603011
  • 636141

Medicade Reported Pricing

65649070141 OSMOPREP TABLET

Pricing Unit: EA | Drug Type: